The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver - A systematic review

Journal of Hepatology

Volumn 62, Issue 2, 2015, Pages 458-468

  Strauss, Otto ^a,b,c   Dunbar, P Rod ^b,c   Bartlett, Adam ^a,b   Phillips, Anthony ^a,b,c  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Antigen presenting cells; Dendritic cells; Human; Kupffer cell; Macrophages; Monocytes; Mononuclear phagocyte system; Review

Indexed keywords

ANTIGEN PRESENTING CELL; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TECHNIQUE; IMMUNOPHENOTYPING; LIVER; MONOCYTE; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; CELLULAR IMMUNITY; CYTOLOGY; IMMUNOLOGY; KUPFFER CELL; REFERENCE VALUE;

FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; KUPFFER CELLS; LIVER; MONONUCLEAR PHAGOCYTE SYSTEM; REFERENCE VALUES;

EID: 84922265129     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.10.006     Document Type: Review

References (135)

1. Trinchieri G. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008-4027.
2. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009; 27: 147-163.
3. Sanchez-Fueyo A, Strom TB. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 2011; 140: 51-64.
4. Protzer U, Maini MK, Knolle PA. Living in the liver: Hepatic infections. Nat Rev Immunol 2012; 12: 201-213.
5. Neil DAH, Hübscher SG. Current views on rejection pathology in liver transplantation. Transpl Int 2010; 23: 971-983.
6. Crispe IN. Liver antigen-presenting cells. J Hepatol 2011; 54: 357-365.
7. Thomson A, Knolle P. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 2010; 10: 753-766.
8. Winau F, Quack C, Darmoise A, Kaufmann S. Starring stellate cells in liver immunology. Curr Opin Immunol 2008; 20: 68-74.
9. Knolle PA, Limmer A. Control of immune responses by savenger liver endothelial cells. Swiss Med Wkly 2003; 133: 501-506.
10. Holz LE, Warren A, Le Couteur DG, Bowen DG, Bertolino P. CD8+ T cell tolerance following antigen recognition on hepatocytes. J Autoimmun 2010; 34: 15-22.
11. Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol 2013; 14: 996-1006.
12. Geissmann F, Gordon S, Hume D, Mowat A, Randolph G, et al. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010; 10: 453.
13. Ginhoux F, Jung S. Monocytes and macrophages: Developmental pathways and tissue homeostasis. Nat Rev Immunol 2014; 14: 392-404.
14. Jakubzick C, Gautier EL, Gibbings SL, Sojka DK, Schlitzer A, Johnson TE, et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 2013; 39: 599-610.
15. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31: 563-604.
16. Gadd VL, Melino M, Roy S, Horsfall L, O'Rourke P, Williams MR, et al. Portal, but not lobular, macrophages express matrix metalloproteinase-9: Association with the ductular reaction and fibrosis in chronic hepatitis C. Liver Int 2013; 33: 569-579.
17. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116: E74-e80.
18. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev 2000; 174: 21-34.
19. Zimmermann H, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012; 3: 56.
20. Aspinall AI, Curbishley SM, Lalor PF, Weston CJ, Blahova M, Liaskou E, et al. CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium. Hepatology 2010; 51: 2030-2039.
21. Antoniades CG, Quaglia A, Taams LS, Mitry RR, Hussain M, Abeles R, et al. Source and characterization of hepatic macrophages in acetaminopheninduced acute liver failure in humans. Hepatology 2012; 56: 735-746.
22. Liaskou E, Zimmermann HW, Li K-K, Oo YH, Suresh S, Stamataki Z, et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology 2013; 57: 385-398.
23. Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A, et al. Functional contribution of elevated circulating and hepatic non-classical CD14+CD16+ monocytes to inflammation and human liver fibrosis. PLoS One 2010; 5: E11049.
24. Wong KL, Tai JJ-Y, Wong W-CC, Han H, Sem X, Yeap W-HH, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011; 118: E16-e31.
25. Collin M, McGovern N, Haniffa M. Human dendritic cell subsets. Immunology 2013; 140: 22-30.
26. Segura E, Touzot M, Bohineust A, Cappuccio A, Chiocchia G, Hosmalin A, et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 2013; 38: 336-348.
27. Angel CE, Chen C-JJJ, Horlacher OC, Winkler S, John T, Browning J, et al. Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 2009; 113: 1257.
28. Wake K. Karl Wilhelm Kupffer and his contributions to modern hepatology. Comp Hepatol 2004; 3: S2.
29. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol 2013; 14: 986-995.
30. Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, Topham DJ, et al. Kupffer cell heterogeneity: Functional properties of bone marrow derived and sessile hepatic macrophages. Blood 2007; 110: 4077-4085.
31. Bardadin KA, Scheuer PJ, Peczek A, Wejman J. Immunocytochemical observations on macrophage populations in normal fetal and adult human liver. J Pathol 1991; 164: 253-259.
32. Burgio VL, Ballardini G, Artini M, Caratozzolo M, Bianchi FB, Levrero M. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology 1998; 27: 1600-1606.
33. Dominguez-Soto A, Aragoneses-Fenoll L, Gomez-Aguado F, Corcuera MTMT, Claria J, Garcia-Monzon C, et al. The pathogen receptor liver and lymph node sinusoidal endotelial cell C-type lectin is expressed in human Kupffer cells and regulated by PU.1. Hepatology 2009; 49: 287-296.
34. Fayyazi A, Scheel O, Werfel T, Schweyer S, Oppermann M, Götze O, et al. The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology 2000; 99: 38-45.
35. Fukuda Y, Imoto M, Koyama Y, Miyazawa Y, Nakano I, Hattori M, et al. Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol Jpn 1991; 26: 37-41.
36. Gaweco AS, Wiesner RH, Yong S, Krom R, Porayko M, Chejfec G, et al. CD40L (CD154) expression in human liver allografts during chronic ductopenic rejection. Liver Transplant Surg 1999; 5: 1-7.
37. Lautenschlager I, Taskinen E, Inkinen K, Lehto VP, Virtanen I, Hayry P. Distribution of the major histocompatibility complex antigens on different cellular components of human liver. Cell Immunol 1984; 85: 191-200.
38. Lefkowitch JH, Haythe JH, Regent N. Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod Pathol 2002; 15: 699-704.
39. Leifeld L, Clemens C, Heller J, Trebicka J, Sauerbruch T, Spengler U. Expression of urotensin II and its receptor in human liver cirrhosis and fulminant hepatic failure. Dig Dis Sci 2010; 55: 1458-1464.
40. Martens JH, Kzhyshkowska J, Falkowski-Hansen M, Schledzewski K, Gratchev A, Mansmann U, et al. Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol 2006; 208: 574-589.
41. Masuda M, Senju S, Fujii SI, Terasaki Y, Takeya M, Hashimoto SI, et al. Identification and immunocytochemical analysis of DCNP1, a dendritic cellassociated nuclear protein. Biochem Biophys Res Commun 2002; 290: 1022-1029.
42. McGuinness PH, Painter D, Davies S, McCaughan GW. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 2000; 46: 260-269.
43. Monnier J, Piquet-Pellorce C, Feige J-JJ, Musso O, Clement B, Turlin B, et al. Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1182-1191.
44. Nakagawa-Toyama Y, Hirano K, Tsujii K, Nishida M, Miyagawa J, Sakai N, et al. Human scavenger receptor class B type I is expressed with cellspecific fashion in both initial and terminal site of reverse cholesterol transport. Atherosclerosis 2005; 183: 75-83.
45. Pungercar J, Viyjak A, Ivanovski G, Krizaj I. Tissue expression and immunolocalization of a novel human cathepsin P. Pflugers Arch 2000; 439: R119-R121.
46. Scoazec JY, Feldmann G. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology 1990; 12: 505-510.
47. Shimada M, Kajiyama K, Hasegawa H, Gion T, Ikeda Y, Shirabe K, et al. Role of adhesion molecule expression and soluble fractions in hepatic resection. J Am Coll Surg 1998; 186: 534-541.
48. Szalowska E, Elferink MGL, Hoek A, Groothuis GMM, Vonk RJ. Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide. J Clin Endocrinol Metab 2009; 94: 3051-3057.
49. Tomita M, Yamamoto K, Kobashi H, Ohmoto M, Tsuji T. Immunohistochemical analysis on the expressions of maturation associated antigens, Fcc receptors and CD14 in normal and diseased human liver macrophages. Int Hepatol Commun 1994; 2: 245-249.
50. Tomokiyo R, Jinnouchi K, Honda M, Wada Y, Hanada N, Hiraoka T, et al. Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors. Atherosclerosis 2002; 161: 123-132.
51. Wood GS, Turner RR, Shiurba RA, Eng L, Warnke RA. Human dendritic cells and macrophages. In situ immunophenotypic definition of subsets that exhibit specific morphologic and microenvironmental characteristics. Am J Pathol 1985; 119: 73-82.
52. Yoshioka T, Yamamoto K, Kobashi H, Tomita M, Tsuji T. Receptor-mediated endocytosis of chemically modified albumins by sinusoidal endothelial cells and Kupffer cells in rat and human liver. Liver 1994; 14: 129-137.
53. Zhao P, Hou N, Lu Y. Fhit protein is preferentially expressed in the nucleus of monocyte-derived cells and its possible biological significance. Histol Histopathol 2006; 21: 915-923.
54. Znoyko I, Sohara N, Spicer SS, Trojanowska M, Reuben A. Expression of oncostatin M and its receptors in normal and cirrhotic human liver. J Hepatol 2005; 43: 893-900.
55. Baldus SE, Zirbes TK, Weidner IC, Flucke U, Dittmar E, Thiele J, et al. Comparative quantitative analysis of macrophage populations defined by CD68 and carbohydrate antigens in normal and pathologically altered human liver tissue. Anal Cell Pathol 1998; 16: 141-150.
56. Tuijnman WB, Van Wichen DF, Schuurman HJ. Tissue distribution of human IgG Fc receptors CD16, CD32, and CD64: An immunohistochemical study. APMIS 1993; 101: 319-329.
57. Alabraba EB, Lai V, Boon L, Wigmore SJ, Adams DH, Afford SC. Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion. Hepatology 2008; 47: 552-562.
58. Arany E, Afford S, Strain AJ, Winwood PJ, Arthur MJ, Hill DJ. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver. J Clin Endocrinol Metab 1994; 79: 1871-1876.
59. Bastin J, Drakesmith H, Rees M, Sargent I, Townsend A. Localisation of proteins of iron metabolism in the human placenta and liver. Br J Haematol 2006; 134: 532-543.
60. Bauer I, Rensing H, Florax A, Ulrich C, Pistorius G, Redl H, et al. Expression pattern and regulation of heme oxygenase-1/heat shock protein 32 in human liver cells. Shock 2003; 20: 116-122.
61. Bode JG, Peters-Regehr T, Kubitz R, Haussinger D. Expression of glutamine synthetase in macrophages. J Histochem Cytochem 2000; 48: 415-421.
62. Brown KE, Broadhurst KA, Mathahs MM, Kladney RD, Fimmel CJ, Srivastava SK, et al. Immunodetection of aldose reductase in normal and diseased human liver. Histol Histopathol 2005; 20: 429-436.
63. Brown KE, Brunt EM, Heinecke JW. Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver. Am J Pathol 2001; 159: 2081-2088.
64. Cope EM, Dilly SA. Kupffer cell numbers during human development. Clin Exp Immunol 1990; 81: 485-488.
65. Esbach S, Pieters MN, van der Boom J, Schouten D, van der Heyde MN, Roholl PJ, et al. Visualization of the uptake and processing of oxidized lowdensity lipoproteins in human and rat liver. Hepatology 1993; 18: 537-545.
66. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G, et al. Isolated hepatic lipocytes and Kupffer cells from normal human liver: Morphological and functional characteristics in primary culture. Hepatology 1992; 15: 234-243.
67. Funaki N, Arii S, Monden K, Higashitsuji H, Furutani M, Mise M, et al. Chemical mediators released by primary-cultured human hepatic macrophages in patients with and without cirrhosis: A study in tumor-bearing patients. Hepatology 1996; 23: 1353-1358.
68. Geuken E, Buis CI, Visser DS, Blokzijl H, Moshage H, Nemes B, et al. Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant 2005; 5: 1875-1885.
69. Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 2001; 97: 288-296.
70. Hinglais N, Kazatchkine MD, Mandet C, Appay MD, Bariety J. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. Lab Invest 1989; 61: 509-514.
71. Huber H, Douglas SD, Fudenberg HH. The IgG receptor: An immunological marker for the characterization of mononuclear cells. Immunology 1969; 17: 7-21.
72. Hume DA, Allan W, Hogan PG, Doe WF. Immunohistochemical characterisation of macrophages in human liver and gastrointestinal tract: Expression of CD4, HLA-DR, OKM1, and the mature macrophage marker 25F9 in normal and diseased tissue. J Leukoc Biol 1987; 42: 474-484.
73. Kitamura Y, Okazaki T, Nagatsuka Y, Hirabayashi Y, Kato S, Hayashi K. Immunohistochemical distribution of phosphatidylglucoside using antiphosphatidylglucoside monoclonal antibody (DIM21). Biochem Biophys Res Commun 2007; 362: 252-255.
74. Kiyohara H, Egami H, Shibata Y, Murata K, Ohshima S, Ogawa M. Light microscopic immunohistochemical analysis of the distribution of group II phospholipase A2 in human digestive organs. J Histochem Cytochem 1992; 40: 1659-1664.
75. Kleinherenbrink-Stins MF, van de Boom JH, Schouten D, Roholl PJ, Niels van der Heyde M, Brouwer A, et al. Visualization of the interaction of native and modified lipoproteins with parenchymal, endothelial and Kupffer cells from human liver. Hepatology 1991; 14: 79-90.
76. Klockars M, Reitamo S. Tissue distribution of lysozyme in man. J Histochem Cytochem 1975; 23: 932-940.
77. Kwekkeboom J, Kuijpers MA, Bruyneel B, Mancham S, De Baar-Heesakkers E, Ijzermans JNM, et al. Expression of CD80 on Kupffer cells is enhanced in cadaveric liver transplants. Clin Exp Immunol 2003; 132: 345-351.
78. Le Bail B, Bioulac-Sage P, Senuita R, Quinton A, Saric J, Balabaud C. Fine structure of hepatic sinusoids and sinusoidal cells in disease. J Electron Microsc Tech 1990; 14: 257-282.
79. Li L, Grenard P, Van Nhieu JT, Julien B, Mallat A, Habib AA, et al. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. Gastroenterology 2003; 125: 460-469.
80. Micklem KJ, Stross WP, Willis AC, Cordell JL, Jones M, Mason DY. Different isoforms of human FcRII distinguished by CDw32 antibodies. J Immunol 1990; 144: 2295-2303.
81. Nusing R, Nüsing R, Sauter G, Fehr P, Dürmüller U, Kasper M, et al. Localization of thromboxane synthase in human tissues by Tu 300. Virchows Arch 1992; 421: 249-254.
82. Okino T, Egami H, Ohmachi H, Takai E, Tamori Y, Nakagawa A, et al. Immunohistochemical analysis of distribution of RON receptor tyrosine kinase in human digestive organs. Dig Dis Sci 2001; 46: 424-429.
83. Rodriguez-Agudo D, Ren S, Hylemon PB, Montañez R, Redford K, Natarajan R, et al. Localization of StarD5 cholesterol binding protein. J Lipid Res 2006; 47: 1168-1175.
84. Roels F, De Prest B, De Pestel G. Liver and chorion cytochemistry. J Inherit Metab Dis 1995; 18: 155-171.
85. Rullier A, Senant N, Kisiel W, Bioulac-Sage P, Balabaud C, Le Bail B, et al. Expression of protease-activated receptors and tissue factor in human liver. Virchows Arch 2006; 448: 46-51.
86. Ueda T, Kohli Y, Abe Y, Katoh T, Ogasawara T, Nojyo Y, et al. Electron microscopic study of endogenous peroxidase activity in human liver macrophages. Histochem Cell Biol 1995; 103: 11-17.
87. Wang J, Greene S, Eriksson LC, Rozell B, Reihnér E, Einarsson C, et al. Human sterol 12a-hydroxylase (CYP8B1) is mainly expressed in hepatocytes in a homogenous pattern. Histochem Cell Biol 2005; 123: 441-446.
88. Becker EL, Forouhar FA, Grunnet ML, Boulay F, Tardif M, Bormann BJ, et al. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res 1998; 292: 129-135.
89. Guo S, Yang C, Mei F, Wu S, Luo N, Fei L, et al. Down-regulation of Z39Ig on macrophages by IFN-gamma in patients with chronic HBV infection. Clin Immunol 2010; 136: 282-291.
90. Kaiserling E, Ruck P, Xiao J-C. Immunoreactivity of neoplastic and nonneoplastic hepatocytes for CD68 and with 3A5, Ki-M1P, and MAC387 lightand electron-microscopic findings. Int Hepatol Commun 1995; 3: 322-329.
91. Moestrup SK, Gliemann J, Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 1992; 269: 375-382.
92. Murakami I, Sarker AB, Hayashi K, Akagi T. Lectin binding patterns in normal liver, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma. An immunohistochemical and immunoelectron microscopic study. Acta Pathol Jpn 1992; 42: 566-572.
93. Osterreicher CH, Penz-Osterreicher M, Grivennikov SI, Guma M, Koltsova EK, Datz C, et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc Natl Acad Sci U S A 2011; 108: 308-313.
94. Zeng L, Takeya M, Takahashi K. AM-3K, a novel monoclonal antibody specific for tissue macrophages and its application to pathological investigation. J Pathol 1996; 178: 207-214.
95. Ballardini G, Fallani M, Bianchi FB, Pisi E. Antigen presenting cells in liver biopsies from patients with primary biliary cirrhosis. Autoimmunity 1989; 3: 135-144.
96. Viñas O, Bataller R, Sancho-Bru P, Ginès P, Berenguer C, Enrich C, et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 2003; 38: 919-929.
97. Bosma BM, Metselaar HJ, Mancham S, Boor PPC, Kusters JG, Kazemier G, et al. Characterization of human liver dendritic cells in liver grafts and perfusates. Liver Transplant 2006; 12: 384-393.
98. Bamboat ZM, Stableford JA, Plitas G, Burt BM, Nguyen HM, Welles AP, et al. Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol 2009; 182: 1901-1911.
99. Goddard S, Youster J, Morgan E, Adams DH. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004; 164: 511-519.
100. Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 2012; 37: 60-73.
101. Ibrahim J, Nguyen AH, Rehman A, Ochi A, Jamal M, Graffeo CS, et al. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology 2012; 143: 1061-1072.
102. Kelly A, Fahey R, Fletcher JM, Keogh C, Carroll AG, Siddachari R, et al. CD141+ myeloid dendritic cells are enriched in healthy human liver. J Hepatol 2014; 60: 135-142.
103. Prickett TC, McKenzie JL, Hart DN. Characterization of interstitial dendritic cells in human liver. Transplantation 1988; 46: 754-761.
104. Angel CE, Lala A, Chen C-JJ, Edgar SG, Ostrovsky LL, Dunbar PR. CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts. Int Immunol 2007; 19: 1271-1279.
105. Angel CE, George E, Brooks AES, Ostrovsky LL, Brown TLH, Dunbar PR. Cutting edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. J Immunol 2006; 176: 5730-5734.
106. Kassianos AJ, Hardy MY, Ju X, Vijayan D, Ding Y, Vulink AJ, et al. Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli. Eur J Immunol 2012; 42: 1512-1522.
107. Steinbrink K, Wölfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997; 159: 4772-4780.
108. Kwekkeboom J, Boor PPC, Sen E, Kusters JG, Drexhage HA, de Jong EC, et al. Human liver myeloid dendritic cells maturate in vivo into effector DC with a poor allogeneic T-cell stimulatory capacity. Transplant Proc 2005; 37: 15-16.
109. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (/). Annu Rev Immunol 2010; 28: 445-489.
110. Trinchieri G. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008-4027.
111. Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med 2010; 207: 1247-1260.
112. Haniffa M, Bigley V, McGovern N, Wang X-N, Teo P, Sng D, et al. CD141+ human migratory dendritic cells are homologous to murine CD103+ dendritic cells and excel at exogenous antigen cross presentation. Immunol. Conf. Annu. Congr. Br. Soc. Immunol. 2011 Liverpool United Kingdom. Conf. 20111205 Conf. End 20111208. Conf. Publ. (var.pagings). 135 (pp 58), 2011. Date of Publication December 2011.
113. Strauss O, Bartlett A. Dendritic cell subset composition in the human liver is more complex than it seems. J Hepatol 2014; 60: 1097-1098.
114. Hart. Characterization of interstitial dendritic cells in human tissues. Transplant Proc 1989; 21: 401-403.
115. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006; 211: 609-618.
116. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012; 336: 86-90.
117. Yona S, Kim K, Wolf Y, Mildner A, Varol D, Breker M, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013; 38: 79-91.
118. Hettinger J, Richards DM, Hansson J, Barra MM, Joschko A-C, Krijgsveld J, et al. Origin of monocytes and macrophages in a committed progenitor. Nat Immunol 2013; 14: 821-830.
119. Park SM, Angel CE, McIntosh JD, Brooks AES, Middleditch M, Chen C-JJ, et al. Sphingosine-1-phosphate lyase is expressed by CD68(+) cells on the parenchymal side of marginal reticular cells in human lymph nodes. Eur J Immunol 2014; 44: 2425-2436.
120. Tiegs G, Lohse AW. Immune tolerance: What is unique about the liver. J Autoimmun 2010; 34: 1-6.
121. Singh R, Bullard J, Kalra M, Assefa S, Kaul AK, Vonfeldt K, et al. Status of bacterial colonization, Toll-like receptor expression and nuclear factorkappa B activation in normal and diseased human livers. Clin Immunol 2011; 138: 41-49.
122. Tu Z, Bozorgzadeh A, Pierce RH, Kurtis J, Crispe IN, Orloff MS. TLRdependent cross talk between human Kupffer cells and NK cells. J Exp Med 2008; 205: 233-244.
123. Balmer ML, Slack E, de Gottardi A, Lawson MAE, Hapfelmeier S, Miele L, et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med 2014; 6: 237ra66.
124. Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 2004; 63: 774-784.
125. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327: 656-661.
126. Feisst V, Brooks AES, Chen C-JJ, Dunbar PR. Characterization of mesenchymal progenitor cell populations directly derived from human dermis. Stem Cells Dev 2014; 23: 631-642.
127. Chow A, Brown B, Merad M. Studying the mononuclear phagocyte system in the molecular age. Nat Rev Immunol 2011; 11: 788-798.
128. Jungermann K, Katz N. Functional specialization of different hepatocyte populations. Physiol Rev 1989; 69: 708-764.
129. Gao Z, Williams GM. Vascular endothelial-cell turnover: A new factor in the vascular microenvironment of the liver. Trends Immunol 2001; 22: 421-422.
130. Lalor PF, Lai WK, Curbishley SM, Shetty S, Adams DH. Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo. World J Gastroenterol 2006; 12: 5429-5439.
131. Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, et al. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant 2006; 20: 624-633.
132. Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, et al. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transpl 2009; 9: 301-308.
133. Fischer SE. Recurrent and de novo malignancies following liver transplantation. Diagn Histopathol 2012; 18: 290-296.
134. Zhong J-HH, Ma L, Wu L-CC, Zhao W, Yuan W-PP, Wu F-XX, et al. Adoptive immunotherapy for postoperative hepatocellular carcinoma: A systematic review. Int J Clin Pract 2012; 66: 21-27.
135. Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology 2011; 53: 1020-1022.